Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aude Echalier

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
British Journal of Haematology|September 5, 2024
Long-term assessment of haematological recovery following somatic genetic rescue in a MYSM1-deficient patient: Implications for in vivo gene therapySophie de Tocqueville, Emmanuel Martin, Quentin Riller, et al.
Essays in Biochemistry|November 10, 2017
The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discoveryAnthony R Bradley, Aude Echalier, Michael Fairhead, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RET<sup>V804M</sup> KinaseRebecca Newton, Bohdan Waszkowycz, Chitra Seewooruthun, et al.
Cancer Research|September 7, 2007
Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinasesKarima Bettayeb, Oscar M Tirado, Séverine Marionneau-Lambot, et al.
Journal of Medicinal Chemistry|December 6, 2013
8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding modeBenoit Carbain, David J Paterson, Elizabeth Anscombe, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
British Journal of Haematology|September 5, 2024
Long-term assessment of haematological recovery following somatic genetic rescue in a MYSM1-deficient patient: Implications for in vivo gene therapySophie de Tocqueville, Emmanuel Martin, Quentin Riller, et al.
Essays in Biochemistry|November 10, 2017
The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discoveryAnthony R Bradley, Aude Echalier, Michael Fairhead, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RET<sup>V804M</sup> KinaseRebecca Newton, Bohdan Waszkowycz, Chitra Seewooruthun, et al.
Cancer Research|September 7, 2007
Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinasesKarima Bettayeb, Oscar M Tirado, Séverine Marionneau-Lambot, et al.
Journal of Medicinal Chemistry|December 6, 2013
8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding modeBenoit Carbain, David J Paterson, Elizabeth Anscombe, et al.
Pageof 3